Consumers call for more government oversight of commercial genetic tests

With its promises of improved diagnostic and treatment outcomes for arthritis, breast cancer, and other conditions, genetic testing is on a trajectory to becoming a mainstay of the healthcare system. But the field is poorly regulated, prompting calls for more government oversight to help ensure patient privacy and testing accuracy, according to an article scheduled for the July 7 issue of Chemical & Engineering News.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news134654981.html">Consumers call for more government oversight of commercial genetic tests</a></p> <p>With its promises of improved diagnostic and treatment outcomes for arthritis, breast cancer, and other conditions, genetic testing is on a trajectory to becoming a mainstay of the healthcare system. But the field is poorly regulated, prompting calls for more government oversight to help ensure patient privacy and testing accuracy, according to an article scheduled for the July 7 issue of Chemical & Engineering News.</p>